Global Generic Injectables Market Research Report 2023(Status and Outlook)

Global Generic Injectables Market Research Report 2023(Status and Outlook)



Report Overview

Generic injectables refer to sterile solutions (including emulsions and suspensions) made of drugs for injection into the body, and sterile powders or concentrated solutions that are prepared into solutions or suspensions before use.

The injection is fast and reliable, not affected by pH, enzymes, food, etc., has no first-pass effect, and can play a systemic or local positioning effect. It is suitable for patients who are not suitable for oral medicine and patients who cannot be taken orally. However, the development and production process of injections is complicated and safe. The body has poor adaptability and high cost.

The Global Generic Injectables Market Size was estimated at USD 30610.00 million in 2022 and is projected to reach USD 38944.47 million by 2029, exhibiting a CAGR of 3.50% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Generic Injectables market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Generic Injectables Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Generic Injectables market in any manner.

Global Generic Injectables Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Hospira (Pfizer Inc.)

Fresenius Kabi

Sandoz (Novartis)

Hikma Pharmaceuticals PLC

Dr. Reddy’s Laboratories Ltd

Grifols

Nichi-Iko Group (Sagent)

Teva Pharmaceutical

Auromedics

Sanofi

Gland Pharma

Endo International PLC

Market Segmentation (by Type)

Small Molecule

Large Molecule

Market Segmentation (by Application)

Surfactants

Quarternaries for Biocides, Swimming Pool and Water Treatment

Flotation Agents

Gasoline Detergents

Corrosion Inhibitors

Rubber Processing Additives

Emulsifier for Herbicides

Textile Softeners

Oilfield Drilling Materials

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Generic Injectables Market

Overview of the regional outlook of the Generic Injectables Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Generic Injectables
1.2 Key Market Segments
1.2.1 Generic Injectables Segment by Type
1.2.2 Generic Injectables Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Generic Injectables Market Overview
2.1 Global Market Overview
2.1.1 Global Generic Injectables Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Generic Injectables Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Generic Injectables Market Competitive Landscape
3.1 Global Generic Injectables Sales by Manufacturers (2018-2023)
3.2 Global Generic Injectables Revenue Market Share by Manufacturers (2018-2023)
3.3 Generic Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Generic Injectables Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Generic Injectables Sales Sites, Area Served, Product Type
3.6 Generic Injectables Market Competitive Situation and Trends
3.6.1 Generic Injectables Market Concentration Rate
3.6.2 Global 5 and 10 Largest Generic Injectables Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Generic Injectables Industry Chain Analysis
4.1 Generic Injectables Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Generic Injectables Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Generic Injectables Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Generic Injectables Sales Market Share by Type (2018-2023)
6.3 Global Generic Injectables Market Size Market Share by Type (2018-2023)
6.4 Global Generic Injectables Price by Type (2018-2023)
7 Generic Injectables Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Generic Injectables Market Sales by Application (2018-2023)
7.3 Global Generic Injectables Market Size (M USD) by Application (2018-2023)
7.4 Global Generic Injectables Sales Growth Rate by Application (2018-2023)
8 Generic Injectables Market Segmentation by Region
8.1 Global Generic Injectables Sales by Region
8.1.1 Global Generic Injectables Sales by Region
8.1.2 Global Generic Injectables Sales Market Share by Region
8.2 North America
8.2.1 North America Generic Injectables Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Generic Injectables Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Generic Injectables Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Generic Injectables Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Generic Injectables Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Hospira (Pfizer Inc.)
9.1.1 Hospira (Pfizer Inc.) Generic Injectables Basic Information
9.1.2 Hospira (Pfizer Inc.) Generic Injectables Product Overview
9.1.3 Hospira (Pfizer Inc.) Generic Injectables Product Market Performance
9.1.4 Hospira (Pfizer Inc.) Business Overview
9.1.5 Hospira (Pfizer Inc.) Generic Injectables SWOT Analysis
9.1.6 Hospira (Pfizer Inc.) Recent Developments
9.2 Fresenius Kabi
9.2.1 Fresenius Kabi Generic Injectables Basic Information
9.2.2 Fresenius Kabi Generic Injectables Product Overview
9.2.3 Fresenius Kabi Generic Injectables Product Market Performance
9.2.4 Fresenius Kabi Business Overview
9.2.5 Fresenius Kabi Generic Injectables SWOT Analysis
9.2.6 Fresenius Kabi Recent Developments
9.3 Sandoz (Novartis)
9.3.1 Sandoz (Novartis) Generic Injectables Basic Information
9.3.2 Sandoz (Novartis) Generic Injectables Product Overview
9.3.3 Sandoz (Novartis) Generic Injectables Product Market Performance
9.3.4 Sandoz (Novartis) Business Overview
9.3.5 Sandoz (Novartis) Generic Injectables SWOT Analysis
9.3.6 Sandoz (Novartis) Recent Developments
9.4 Hikma Pharmaceuticals PLC
9.4.1 Hikma Pharmaceuticals PLC Generic Injectables Basic Information
9.4.2 Hikma Pharmaceuticals PLC Generic Injectables Product Overview
9.4.3 Hikma Pharmaceuticals PLC Generic Injectables Product Market Performance
9.4.4 Hikma Pharmaceuticals PLC Business Overview
9.4.5 Hikma Pharmaceuticals PLC Generic Injectables SWOT Analysis
9.4.6 Hikma Pharmaceuticals PLC Recent Developments
9.5 Dr. Reddy’s Laboratories Ltd
9.5.1 Dr. Reddy’s Laboratories Ltd Generic Injectables Basic Information
9.5.2 Dr. Reddy’s Laboratories Ltd Generic Injectables Product Overview
9.5.3 Dr. Reddy’s Laboratories Ltd Generic Injectables Product Market Performance
9.5.4 Dr. Reddy’s Laboratories Ltd Business Overview
9.5.5 Dr. Reddy’s Laboratories Ltd Generic Injectables SWOT Analysis
9.5.6 Dr. Reddy’s Laboratories Ltd Recent Developments
9.6 Grifols
9.6.1 Grifols Generic Injectables Basic Information
9.6.2 Grifols Generic Injectables Product Overview
9.6.3 Grifols Generic Injectables Product Market Performance
9.6.4 Grifols Business Overview
9.6.5 Grifols Recent Developments
9.7 Nichi-Iko Group (Sagent)
9.7.1 Nichi-Iko Group (Sagent) Generic Injectables Basic Information
9.7.2 Nichi-Iko Group (Sagent) Generic Injectables Product Overview
9.7.3 Nichi-Iko Group (Sagent) Generic Injectables Product Market Performance
9.7.4 Nichi-Iko Group (Sagent) Business Overview
9.7.5 Nichi-Iko Group (Sagent) Recent Developments
9.8 Teva Pharmaceutical
9.8.1 Teva Pharmaceutical Generic Injectables Basic Information
9.8.2 Teva Pharmaceutical Generic Injectables Product Overview
9.8.3 Teva Pharmaceutical Generic Injectables Product Market Performance
9.8.4 Teva Pharmaceutical Business Overview
9.8.5 Teva Pharmaceutical Recent Developments
9.9 Auromedics
9.9.1 Auromedics Generic Injectables Basic Information
9.9.2 Auromedics Generic Injectables Product Overview
9.9.3 Auromedics Generic Injectables Product Market Performance
9.9.4 Auromedics Business Overview
9.9.5 Auromedics Recent Developments
9.10 Sanofi
9.10.1 Sanofi Generic Injectables Basic Information
9.10.2 Sanofi Generic Injectables Product Overview
9.10.3 Sanofi Generic Injectables Product Market Performance
9.10.4 Sanofi Business Overview
9.10.5 Sanofi Recent Developments
9.11 Gland Pharma
9.11.1 Gland Pharma Generic Injectables Basic Information
9.11.2 Gland Pharma Generic Injectables Product Overview
9.11.3 Gland Pharma Generic Injectables Product Market Performance
9.11.4 Gland Pharma Business Overview
9.11.5 Gland Pharma Recent Developments
9.12 Endo International PLC
9.12.1 Endo International PLC Generic Injectables Basic Information
9.12.2 Endo International PLC Generic Injectables Product Overview
9.12.3 Endo International PLC Generic Injectables Product Market Performance
9.12.4 Endo International PLC Business Overview
9.12.5 Endo International PLC Recent Developments
10 Generic Injectables Market Forecast by Region
10.1 Global Generic Injectables Market Size Forecast
10.2 Global Generic Injectables Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Generic Injectables Market Size Forecast by Country
10.2.3 Asia Pacific Generic Injectables Market Size Forecast by Region
10.2.4 South America Generic Injectables Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Generic Injectables by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Generic Injectables Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Generic Injectables by Type (2024-2029)
11.1.2 Global Generic Injectables Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Generic Injectables by Type (2024-2029)
11.2 Global Generic Injectables Market Forecast by Application (2024-2029)
11.2.1 Global Generic Injectables Sales (K Units) Forecast by Application
11.2.2 Global Generic Injectables Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings